Biomerica Inc.
- Share via
The Newport Beach medical-technology firm recorded a net loss of $592,027, or 12 cents a share, for the second quarter ended Nov. 30, compared with a net loss of $674,713, or 15 cents a share, for the like period a year earlier. Sales rose 15% to $2.3 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
